Kraig M Yager

Title: Kraig M Yager: Innovator in Pharmaceutical Chemistry

Introduction

Kraig M Yager is a notable inventor based in Snohomish, WA (US), recognized for his contributions to pharmaceutical chemistry. He holds two patents that focus on innovative compounds with significant therapeutic potential. His work primarily addresses inflammatory disorders and the synthesis of novel pharmaceutical agents.

Latest Patents

Yager's latest patents include "Pyrimidinecarboxamide derivatives and their use as anti-inflammatory agents." This invention is directed to compounds that are useful in treating inflammatory disorders in mammals. The compounds are characterized by a specific formula, where various substituents are defined. Another significant patent is "Pharmaceutical uses and synthesis of nicotinanilide-N-oxides." This patent discloses nicotinanilide-N-oxide compounds, methods for their production, and their applications in various therapies.

Career Highlights

Kraig M Yager has made substantial contributions to the field of pharmaceutical research. His innovative approaches have led to the development of compounds that hold promise for treating various health conditions. He is currently associated with UCB S.A., a company known for its focus on biopharmaceuticals.

Collaborations

Yager has collaborated with notable colleagues in his field, including Theodore A Baughman and Jim P Boyce. These collaborations have likely enhanced the scope and impact of his research.

Conclusion

Kraig M Yager's work exemplifies the intersection of innovation and pharmaceutical science. His patents reflect a commitment to developing effective treatments for inflammatory disorders, showcasing his role as a significant contributor to the field.